<DOC>
	<DOC>NCT02401334</DOC>
	<brief_summary>This prospective clinical study will evaluate the safety and efficacy of the Cook® Antimicrobial Hernia Repair Device containing an antimicrobial to reinforce soft tissue during ventral or incisional hernia repair in clean-contaminated, contaminated, and dirty-infected (i.e., Class II, Class III, and Class IV) surgical fields. Up to 30 patients will be treated with the Cook® Antimicrobial Hernia Repair Device and patients will be followed for 12 months.</brief_summary>
	<brief_title>Antimicrobial Hernia Repair Device Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia, Ventral</mesh_term>
	<mesh_term>Incisional Hernia</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Patient presents with a ventral or incisional hernia that is to be surgically corrected using open repair technique Body Mass Index (BMI) &lt; 25. Body weight &lt; 45 kg Glycosylated Hemoglobin (Hgb A1c) &gt; 10% Albumin &lt; 2.5 g/dL or prealbumin &lt; 5.0 mg/dL Renal insufficiency, as determined by an estimated glomerular filtration rate (GFR) &lt; 60 mL/min/1.73 m2 Known allergies to study device components Other relevant exclusion criteria apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>